These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 7909078

  • 21. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
    Paweł K, Hauser J, Skibińska M, Szczepankiewicz A, Dmitrzak-Weglarz M, Gorzkowska K, Pawlak J, Czerski PM.
    Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
    [Abstract] [Full Text] [Related]

  • 22. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.
    Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC.
    Am J Med Genet B Neuropsychiatr Genet; 2003 May 15; 119B(1):28-34. PubMed ID: 12707934
    [Abstract] [Full Text] [Related]

  • 23. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia.
    Serretti A, Macciardi F, Smeraldi E.
    Schizophr Res; 1998 Nov 30; 34(3):207-10. PubMed ID: 9850987
    [Abstract] [Full Text] [Related]

  • 24. Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia.
    Zahari Z, Teh LK, Ismail R, Razali SM.
    Psychiatr Genet; 2011 Aug 30; 21(4):183-9. PubMed ID: 21206399
    [Abstract] [Full Text] [Related]

  • 25. Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis.
    Zou YF, Wang F, Feng XL, Li WF, Tian YH, Tao JH, Pan FM, Huang F.
    J Affect Disord; 2012 Feb 30; 136(3):229-37. PubMed ID: 21130502
    [Abstract] [Full Text] [Related]

  • 26. Association study of bipolar disorder using a functional polymorphism (Ser311-->Cys) in the dopamine D2 receptor gene.
    Craddock N, Roberts Q, Williams N, McGuffin P, Owen MJ.
    Psychiatr Genet; 1995 Feb 30; 5(2):63-5. PubMed ID: 7551964
    [Abstract] [Full Text] [Related]

  • 27. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
    Lawford BR, Young RM, Swagell CD, Barnes M, Burton SC, Ward WK, Heslop KR, Shadforth S, van Daal A, Morris CP.
    Schizophr Res; 2005 Feb 01; 73(1):31-7. PubMed ID: 15567074
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Response to "DRD2 Ser311Cys polymorphism and risk of schizophrenia".
    Yao J, Wang BJ.
    Am J Med Genet B Neuropsychiatr Genet; 2015 Apr 01; 168B(3):223. PubMed ID: 25711779
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
    Kapelski P, Czerski PM, Godlewski S, Dmitrzak-Weglarz M, Hauser J.
    Psychiatr Pol; 2002 Apr 01; 36(3):413-9. PubMed ID: 12149917
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Association of schizophrenia with a promoter polymorphism in the dopamine D2 receptor gene].
    Peng DH, Wang GH, Cheng ZL, Zhang DX, Jiang KD.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb 01; 22(1):94-5. PubMed ID: 15696493
    [Abstract] [Full Text] [Related]

  • 39. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I, Takeuchi S, Katsumi A, Mori A, Kanno K, Yang Q, Mashiko H, Numata Y, Niwa S.
    J Clin Psychopharmacol; 2012 Feb 01; 32(1):106-9. PubMed ID: 22198450
    [Abstract] [Full Text] [Related]

  • 40. [The Cys allele of the DRD2 (Ser311Cys polymorphism) is associated with schizophrenia and worse sustained attention in patients].
    Golimbet VE, Lebedeva IS, Monakhov MV, Korovaĭtseva GI, Lezheĭko TV, Abramova LI, Kaleda VG, Karpov VL.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009 Feb 01; 109(9):67-70. PubMed ID: 19770837
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.